274 related articles for article (PubMed ID: 11215087)
21. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
22. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments.
Department of Health and Human Services (HHS)
Fed Regist; 2005 Feb; 70(22):5543-65. PubMed ID: 15690579
[TBL] [Abstract][Full Text] [Related]
23. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
24. An ethical analysis of clinical trials for AIDS drugs in correctional settings.
Dubler NN
Med Health R I; 2000 Dec; 83(12):390-2. PubMed ID: 11190126
[No Abstract] [Full Text] [Related]
25. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
[TBL] [Abstract][Full Text] [Related]
26. AIDS researchers seek criteria for vaccines.
Check E
Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
[No Abstract] [Full Text] [Related]
27. Human immunodeficiency virus in correctional facilities: a review.
Spaulding A; Stephenson B; Macalino G; Ruby W; Clarke JG; Flanigan TP
Clin Infect Dis; 2002 Aug; 35(3):305-12. PubMed ID: 12115097
[TBL] [Abstract][Full Text] [Related]
28. Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice.
Fed Regist; 1998 Nov; 63(216 Pt 1):60353-6. PubMed ID: 10187395
[TBL] [Abstract][Full Text] [Related]
29. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
Nightingale SL
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial that led to FDA approval of zidovudine is published.
Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341
[No Abstract] [Full Text] [Related]
31. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
32. AmFAR extols FDA on rapid approval of two protease inhibitors.
AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
[No Abstract] [Full Text] [Related]
33. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
34. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
[TBL] [Abstract][Full Text] [Related]
35. FDA 'remains committed' to quick approval of AIDS drugs.
Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
[No Abstract] [Full Text] [Related]
36. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
[TBL] [Abstract][Full Text] [Related]
37. Navigating federalwide assurance requirements when conducting research in community-based care settings.
Cartwright JC; Hickman SE; Bevan L; Shupert CL
J Am Geriatr Soc; 2004 Sep; 52(9):1567-71. PubMed ID: 15341563
[TBL] [Abstract][Full Text] [Related]
38. FDA clearance for ritonavir in children with AIDS.
AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
[No Abstract] [Full Text] [Related]
39. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
40. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
Jansson RL
Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
